98 related articles for article (PubMed ID: 18666239)
1. Children with chronic hepatitis C: what future?
Iorio R; Cirillo F; Terlizzi V; Giannattasio A
Hepatology; 2008 Aug; 48(2):691-2; author reply 692. PubMed ID: 18666239
[No Abstract] [Full Text] [Related]
2. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
[TBL] [Abstract][Full Text] [Related]
3. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
4. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
[TBL] [Abstract][Full Text] [Related]
5. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease.
Forman LM; Lucey MR
Hepatology; 2001 Feb; 33(2):473-5. PubMed ID: 11172352
[No Abstract] [Full Text] [Related]
6. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
7. Autonomic dysfunction: often present but usually ignored in patients with liver disease.
Salerno F; Cazzaniga M
Liver Int; 2009 Nov; 29(10):1451-3. PubMed ID: 19811611
[No Abstract] [Full Text] [Related]
8. Natural killer cells play divergent roles in shaping the outcome of hepatitis C virus recurrence following liver transplantation.
Golden-Mason L
Liver Transpl; 2009 Apr; 15(4):357-9. PubMed ID: 19326413
[No Abstract] [Full Text] [Related]
9. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
Murcia J; Portilla J; Bedia M; Palazón JM; Sánchez-Payá J; Saiz de la Hoya P; Payá A; Boix V; Merino E; Reus S
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C.
Lindsay KL; Rosenberg J
West J Med; 1998 Dec; 169(6):372-3. PubMed ID: 9866437
[No Abstract] [Full Text] [Related]
11. Is severe liver disease a common outcome for people with chronic hepatitis C?
Dore GJ; Freeman AJ; Law M; Kaldor JM
J Gastroenterol Hepatol; 2002 Apr; 17(4):423-30. PubMed ID: 11982723
[TBL] [Abstract][Full Text] [Related]
12. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
13. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive biomarkers of liver fibrosis in liver transplant patients with hepatitis C: can we avoid liver biopsies?
Berenguer M
Dig Liver Dis; 2009 Mar; 41(3):226-8. PubMed ID: 19138576
[No Abstract] [Full Text] [Related]
15. Prevalence of human cytomegalovirus co-infection in patients with chronic viral hepatitis B and C: a comparison of clinical and histological aspects.
Bayram A; Ozkur A; Erkilic S
J Clin Virol; 2009 Jul; 45(3):212-7. PubMed ID: 19497785
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.
Zhong YD; Yang YF
Hepatology; 2008 Oct; 48(4):1348; author reply 1348. PubMed ID: 18792394
[No Abstract] [Full Text] [Related]
17. Disease progression and the risk factor analysis for chronic hepatitis C.
Sinn DH; Paik SW; Kang P; Kil JS; Park SU; Lee SY; Song SM; Gwak GY; Choi MS; Lee JH; Koh KC; Yoo BC
Liver Int; 2008 Dec; 28(10):1363-9. PubMed ID: 18710426
[TBL] [Abstract][Full Text] [Related]
18. Re: Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.
Chen TH; Chiu SY
Hepatology; 2008 Oct; 48(4):1348-9. PubMed ID: 18792397
[No Abstract] [Full Text] [Related]
19. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
Bedossa P
Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
[TBL] [Abstract][Full Text] [Related]
20. Severe migraine attacks during treatment of chronic hepatitis C.
Kocaman O; Kocaman G; Senturk O
Eur J Intern Med; 2009 May; 20(3):e74. PubMed ID: 19393484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
